Illumina Files 10-Q for Q2 2024
Ticker: ILMN · Form: 10-Q · Filed: Aug 7, 2024 · CIK: 1110803
| Field | Detail |
|---|---|
| Company | Illumina, INC. (ILMN) |
| Form Type | 10-Q |
| Filed Date | Aug 7, 2024 |
| Risk Level | medium |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, disclosure
Related Tickers: ILMN
TL;DR
Illumina's Q2 2024 10-Q is in. Check financials.
AI Summary
Illumina, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter of 2024. Key financial figures and business segment information are presented, reflecting the company's ongoing activities in the laboratory analytical instruments sector.
Why It Matters
This filing provides investors and analysts with a detailed look at Illumina's financial health and operational performance during the second quarter of 2024, impacting investment decisions.
Risk Assessment
Risk Level: medium — 10-Q filings are standard disclosures, but the specific financial details and business context within this report could reveal material risks or opportunities.
Key Numbers
- N/A — Revenue (Specific revenue figures for Q2 2024 are not directly extracted in this snippet.)
- N/A — Net Income (Specific net income figures for Q2 2024 are not directly extracted in this snippet.)
- N/A — Earnings Per Share (Specific EPS figures for Q2 2024 are not directly extracted in this snippet.)
Key Players & Entities
- ILLUMINA, INC. (company) — Filer
- 20240630 (date) — Period of Report
- 20240807 (date) — Filed as of Date
- SAN DIEGO (location) — Business Address City
- 330804655 (identifier) — IRS Number
FAQ
What were Illumina's total revenues for the second quarter of 2024?
The provided text snippet does not contain specific revenue figures for the second quarter of 2024.
What is the company's reported net income for the period ending June 30, 2024?
Specific net income details for the period ending June 30, 2024, are not available in this excerpt.
Did Illumina report any goodwill and intangible asset impairment during this period?
The filing mentions 'GoodwillAndIntangibleAssetImpairment' as a potential item, but specific impairment amounts are not detailed in this snippet.
What is the company's fiscal year end date?
Illumina's fiscal year ends on December 29 (1229).
What is the SEC file number for Illumina?
Illumina's SEC file number is 001-35406.
Filing Stats: 4,837 words · 19 min read · ~16 pages · Grade level 19 · Accepted 2024-08-07 17:28:56
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value ILMN The Nasdaq Stock Market
Filing Documents
- ilmn-20240630.htm (10-Q) — 1963KB
- ex31amendedandrestatedbyla.htm (EX-3.1) — 251KB
- ex106jgoswamiretentionagre.htm (EX-10.6) — 27KB
- ex107jgoswamiseparationagr.htm (EX-10.7) — 43KB
- fy24q2ex311.htm (EX-31.1) — 15KB
- fy24q2ex312.htm (EX-31.2) — 14KB
- fy24q2ex321.htm (EX-32.1) — 7KB
- fy24q2ex322.htm (EX-32.2) — 7KB
- ilmn-20240630_g1.jpg (GRAPHIC) — 7KB
- 0001110803-24-000044.txt ( ) — 10057KB
- ilmn-20240630.xsd (EX-101.SCH) — 60KB
- ilmn-20240630_cal.xml (EX-101.CAL) — 85KB
- ilmn-20240630_def.xml (EX-101.DEF) — 390KB
- ilmn-20240630_lab.xml (EX-101.LAB) — 800KB
- ilmn-20240630_pre.xml (EX-101.PRE) — 592KB
- ilmn-20240630_htm.xml (XML) — 1421KB
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 41 OTHER KEY INFORMATION
Controls and Procedures
Controls and Procedures 41
Legal Proceedings
Legal Proceedings 41
Risk Factors
Risk Factors 41 Share Repurchases and Sales 44 Adoptions, Modifications or Terminations of Trading Plans 44 Other Information 44 Exhibits 44 Form 10-Q Cross-Reference Index 47 2 Table of Contents Consideration Regarding Forward-Looking Statements This Quarterly Report on Form 10-Q contains, and our officers and representatives may from time to time make, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Words such as: "anticipate," "intend," "plan," "goal," "seek," "believe," "continue," "project," "estimate," "expect," "strategy," "future," "likely," "may," "potential," "predict," "should," "will," or similar words or phrases, or the negatives of these words, may identify forward-looking statements, but the absence of these words does not necessarily mean that a statement is not forward looking. Examples of forward-looking statements include, among others, statements we make regarding: our expectations as to our future financial performance, results of operations, or other operational results or metrics; the benefits that we expect will result from our business activities and certain transactions we have completed, or may complete, such as product introductions, increased revenue, decreased expenses, and avoided expenses and expenditures; our expectations of the effect on our financial condition of claims, litigation, contingent liabilities, and governmental investigations, proceedings, and regulations; our strategies or expectations for product development, market position, financial results, and reserves; our ability to successfully implement cost reduction plans in a timely manner and the possibility that costs associated with our cost reduction plans are greater than we anticipate; risks relating to the recent divestiture of GRAIL, Inc. (f/k/a GRAIL, LLC) (GRAIL); the European Commission proceedings in respect of our acquisition and divestitur